These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 33454595)

  • 1. The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators.
    Habib HM; Ibrahim S; Zaim A; Ibrahim WH
    Biomed Pharmacother; 2021 Apr; 136():111228. PubMed ID: 33454595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Infection Dysregulates Host Iron (Fe)-Redox Homeostasis (Fe-R-H): Role of Fe-Redox Regulators, Ferroptosis Inhibitors, Anticoagulants, and Iron-Chelators in COVID-19 Control.
    Naidu SAG; Clemens RA; Naidu AS
    J Diet Suppl; 2023; 20(2):312-371. PubMed ID: 35603834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of iron chelators in diseases associated with iron mismanagement.
    Weinberg ED
    J Pharm Pharmacol; 2006 May; 58(5):575-84. PubMed ID: 16640825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Can Cellular Redox, Iron, and Reactive Oxygen Species Suggest About the Mechanisms and Potential Therapy of COVID-19?
    Muhoberac BB
    Front Cell Infect Microbiol; 2020; 10():569709. PubMed ID: 33381464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy.
    Perricone C; Bartoloni E; Bursi R; Cafaro G; Guidelli GM; Shoenfeld Y; Gerli R
    Immunol Res; 2020 Aug; 68(4):213-224. PubMed ID: 32681497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron chelators for the treatment of iron overload disease: relationship between structure, redox activity, and toxicity.
    Chaston TB; Richardson DR
    Am J Hematol; 2003 Jul; 73(3):200-10. PubMed ID: 12827659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Influence of Viral Infections on Iron Homeostasis and the Potential for Lactoferrin as a Therapeutic in the Age of the SARS-CoV-2 Pandemic.
    Ward JL; Torres-Gonzalez M; Ammons MCB
    Nutrients; 2022 Jul; 14(15):. PubMed ID: 35956266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron-mediated oxidative cell death is a potential contributor to neuronal dysfunction induced by neonatal hemolytic hyperbilirubinemia.
    Viktorinova A
    Arch Biochem Biophys; 2018 Sep; 654():185-193. PubMed ID: 30059654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolution of iron chelators for the treatment of iron overload disease and cancer.
    Kalinowski DS; Richardson DR
    Pharmacol Rev; 2005 Dec; 57(4):547-83. PubMed ID: 16382108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview on in vitro and in vivo antiviral activity of lactoferrin: its efficacy against SARS-CoV-2 infection.
    Rosa L; Cutone A; Conte MP; Campione E; Bianchi L; Valenti P
    Biometals; 2023 Jun; 36(3):417-436. PubMed ID: 35920949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron overload cardiomyopathy: Using the latest evidence to inform future applications.
    Kumfu S; Chattipakorn SC; Chattipakorn N
    Exp Biol Med (Maywood); 2022 Apr; 247(7):574-583. PubMed ID: 35130741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical features of in use and in progress chelators for iron overload.
    Nurchi VM; Crisponi G; Lachowicz JI; Medici S; Peana M; Zoroddu MA
    J Trace Elem Med Biol; 2016 Dec; 38():10-18. PubMed ID: 27365273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactoferrin, a potential iron-chelator as an adjunct treatment for mucormycosis - A comprehensive review.
    Singh A; Ahmad N; Varadarajan A; Vikram N; Singh TP; Sharma S; Sharma P
    Int J Biol Macromol; 2021 Sep; 187():988-998. PubMed ID: 34324905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective Potential of Iron Chelators and Prochelators.
    Jansová H; Šimůnek T
    Curr Med Chem; 2019; 26(2):288-301. PubMed ID: 28933303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commentary: Could iron chelators prove to be useful as an adjunct to COVID-19 Treatment Regimens?
    Dalamaga M; Karampela I; Mantzoros CS
    Metabolism; 2020 Jul; 108():154260. PubMed ID: 32418885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Macromolecular Iron Chelators.
    Bulbake U; Singh A; Domb AJ; Khan W
    Curr Med Chem; 2019; 26(2):323-334. PubMed ID: 30182850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New developments in iron chelators.
    Cunningham MJ; Nathan DG
    Curr Opin Hematol; 2005 Mar; 12(2):129-34. PubMed ID: 15725903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of lactoferrin in the iron metabolism. Part II. Antimicrobial and antiinflammatory effect of lactoferrin by chelation of iron].
    Artym J
    Postepy Hig Med Dosw (Online); 2010 Nov; 64():604-16. PubMed ID: 21160095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic and natural iron chelators: therapeutic potential and clinical use.
    Hatcher HC; Singh RN; Torti FM; Torti SV
    Future Med Chem; 2009 Dec; 1(9):1643-70. PubMed ID: 21425984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin: Potential avenue for treating iron overload disorders.
    Yang J; Tang Q; Zeng Y
    Ageing Res Rev; 2022 Nov; 81():101717. PubMed ID: 35961513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.